Skip to main content
Top
Published in: Supportive Care in Cancer 12/2020

01-12-2020 | Editorial

Relevance of tumor boards for cancer rehabilitation

Authors: Richard Crevenna, Mohammad Keilani

Published in: Supportive Care in Cancer | Issue 12/2020

Login to get access

Excerpt

Modern cancer care with increasing survival rates puts the focus on rehabilitation in cancer survivorship which has been shown to have a key role in improving patients’ quality of life, functional performance, and participation [1]. There is an increasing interest to optimize the rehabilitation process, namely to have both—effective and also safe rehabilitation measures [1]. …
Literature
2.
go back to reference Yamanaka N, Tsukamoto S, Ishida Y, Shigematsu H, Hasegawa M, Sajiki M, Mano T, Tanaka Y, Kido A (2020) Clinical questions on rehabilitation in cancer patients with skeletal metastasis: a content analysis of the multidisciplinary tumor board records. Support Care Cancer. https://doi.org/10.1007/s00520-020-05696-3 Yamanaka N, Tsukamoto S, Ishida Y, Shigematsu H, Hasegawa M, Sajiki M, Mano T, Tanaka Y, Kido A (2020) Clinical questions on rehabilitation in cancer patients with skeletal metastasis: a content analysis of the multidisciplinary tumor board records. Support Care Cancer. https://​doi.​org/​10.​1007/​s00520-020-05696-3
Metadata
Title
Relevance of tumor boards for cancer rehabilitation
Authors
Richard Crevenna
Mohammad Keilani
Publication date
01-12-2020
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 12/2020
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-020-05769-3

Other articles of this Issue 12/2020

Supportive Care in Cancer 12/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine